As of 4:00pm ET
| -0.65 / -1.17%|
The 22 analysts offering 12-month price forecasts for Bristol-Myers Squibb have a median target of 66.50, with a high estimate of 100.00 and a low estimate of 50.00. The median estimate represents a +20.71% increase from the last price of 55.09.
The current consensus among 26 polled investment analysts is to Hold stock in Bristol-Myers Squibb. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.